The identification of SMA discordant families with asymptomatic individuals carrying homozygous SMN1 deletions and three to four SMN2 copies led to the discovery of two SMA genetic modifiers, plastin 3 (PLS3) and neurocalcin δ (NCALD), in humans [28,29]. Here, PLS3 is linked to proximal spinal muscular atrophy.